USPTO serial 77326262
FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CROSS, TRACY L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
Beverly Hills, CA
Other trademarks owned by Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
Beverly Hills, CA
Other trademarks owned by Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marya Lenn Yee, Esq.
MARYA LENN YEE, ESQ. DONOVAN & YEE LLP110 GREENE ST STE 700NEW YORK, NY 10012-3838UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting public awareness of the need for career growth for diversity and minority individuals in the pharmaceutical and healthcare industries; promoting public awareness of enrolling diversity students in the pharmaceutical education programs of others and in promoting public awareness in diversity career advancement and leadership in the pharmaceutical industry; human resource consulting services in the field of diversity human resource development in the pharmaceutical industry | ACTIVE | — |
| 036 | Charitable fund raising targeted toward diversity employment in the pharmaceutical and healthcare industries | ACTIVE | — |
| 041 | Education services, namely, providing classes, seminars and workshops for the public and pharmaceutical and healthcare communities in the field of values and benefits of diverse cultural and ethnic participation; Education services, namely, providing classes, seminars and workshops in the field of diversity employment in the pharmaceutical and healthcare industries; conducting awards programs for individuals and corporations who have made significant charitable contributions benefiting minority populations in the pharmaceutical industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
- Other trademarks owned by Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Similar marks named FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 27, 2009 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 27, 2009 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 23, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 30, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 28, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 26, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 4, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 4, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2008 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 8, 2008 | ALIE | ASSIGNED TO LIE | — |
| Nov 26, 2007 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 16, 2007 | MDSM | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Nov 15, 2007 | NWAP | NEW APPLICATION ENTERED | — |